7Baggers
 Aligos Therapeutics stock reaffirmed Buy at H.C. Wainwright  Investing.com Fri, 19 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 21:30:27  newser.com Wed, 17 Sep 2025 02:30:27 GMT
 published on: 2025-09-16 02:21:46  newser.com Tue, 16 Sep 2025 07:21:46 GMT
 aligos therapeutics' (algs) buy rating reaffirmed at hc wainwright  MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
 Lawrence M. Blatt on Taking the Leap from Scientist to Founder  PharmExec Mon, 15 Sep 2025 07:00:00 GMT
 aligos therapeutics announces inducement grants under nasdaq listing rule 5635  Investing News Network Wed, 10 Sep 2025 12:44:07 GMT
 aligos therapeutics, inc. $algs shares sold by ecor1 capital llc  MarketBeat Tue, 09 Sep 2025 09:44:44 GMT
 aligos therapeutics describes new pd-1/pd-l1 interaction inhibitors  BioWorld MedTech Wed, 03 Sep 2025 13:00:00 GMT
 published on: 2025-08-31 13:06:57  Newser Sun, 31 Aug 2025 18:06:57 GMT
 published on: 2025-08-30 00:39:34  Newser Sat, 30 Aug 2025 05:39:34 GMT
 published on: 2025-08-29 14:33:52  Newser Fri, 29 Aug 2025 19:33:52 GMT

Aligos Therapeutics, Inc
(NASDAQ:ALGS) 

ALGS stock logo

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a synthetic oligonucleotide that is in Phase I clinical trial for the treatment of chronic h...

Founded: 2018
Full Time Employees: 73
CEO: Lawrence M. Blatt  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends